Jupiter Orphan Therapeutics

About:

Jupiter Orphan Therapeutics, Inc. Developing therapies for rare diseases linked to single gene deficiencies.

Website: http://www.jupiterorphan.com/

Top Investors: Tarnagulla Ventures

Description:

Jupiter Orphan Therapeutics, Inc. (JOT) is a specialty pharmaceutical company developing therapies for rare diseases linked to single gene deficiencies. JOT, a Delaware Corporation with it's principal office located in Jupiter, FL, USA, was founded in the summer of 2015. In its short period of operations, JOT has assembled a very strong management and scientific team as well as defined three pipeline products which of one is already in Phase II.

Total Funding Amount:

$2.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jupiter, Florida, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)jupiterorphan.com

Founders:

Christer Rosén, Jacob Uittenbogaard

Number of Employees:

11-50

Last Funding Date:

2017-01-05

IPO Status:

Private

Industries: